Cargando…

Pharmacists as facilitators of pharmacogenomic guidance for antidepressant drug selection and dosing

Detalles Bibliográficos
Autor principal:	Bishop, Jeffrey R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301590/ https://www.ncbi.nlm.nih.gov/pubmed/34058073 http://dx.doi.org/10.1111/cts.13057

Ejemplares similares

Using pharmacogenomics and therapeutic drug monitoring to guide drug selection and dosing in outpatient mental health comprehensive medication management
por: Brown, Jacob T., et al.
Publicado: (2020)

Pharmacogenomics in depression and antidepressants
por: Bondy, Brigitta
Publicado: (2005)

The implications of pharmacogenomics in oncology
por: Latimer, Jean J.
Publicado: (2023)

Integrating epigenomics into pharmacogenomic studies
por: Zhang, Wei, et al.
Publicado: (2008)

Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)
por: Bienfait, Karina, et al.
Publicado: (2021)

Pharmacogenomics of antidepressant treatment effects
por: Licinio, Julio, et al.
Publicado: (2011)

Guidance by physicians and pharmacists during antidepressant therapy: patients’ needs and suggestions for improvement
por: Nederlof, Mariёtte, et al.
Publicado: (2017)

Emerging strategies and applications of pharmacogenomics
por: Milos, Patrice M, et al.
Publicado: (2004)

Population Pharmacogenomics for Health Equity
por: Jordan, I. King, et al.
Publicado: (2023)

Pharmacogenomics cascade testing (PhaCT): a novel approach for preemptive pharmacogenomics testing to optimize medication therapy
por: Roosan, Don, et al.
Publicado: (2020)

Relevance of Pharmacogenomics to the Safe Use of Antimicrobials
por: Daly, Ann K.
Publicado: (2023)

Pharmacogenomic strategy for individualizing antidepressant therapy
por: Lin, Keh-Ming, et al.
Publicado: (2008)

Virtual Pharmacist: A Platform for Pharmacogenomics
por: Cheng, Ronghai, et al.
Publicado: (2015)

Basic Concepts in Genetics and Pharmacogenomics for Pharmacists
por: Orrico, Kathleen B
Publicado: (2019)

Practical guidance to advisors of residents on the fellowship selection process
por: Alweis, Richard, et al.
Publicado: (2021)

Bridging the Gap in Tobacco Cessation Services: Utilizing Community Pharmacists to Facilitate Transitions of Care in the USA
por: Newlon, Jenny, et al.
Publicado: (2022)

Development of the pharmacogenomics and genomics literacy framework for pharmacists
por: Rahma, Azhar T., et al.
Publicado: (2021)

Deciphering next-generation pharmacogenomics: an information technology perspective
por: Potamias, George, et al.
Publicado: (2014)

PharmCAT: A Pharmacogenomics Clinical Annotation Tool
por: Klein, Teri E., et al.
Publicado: (2017)

Pharmacogenetics and pharmacogenomics in glaucoma therapeutics: the way to personalized therapy
por: Liao, Shiyu, et al.
Publicado: (2023)

Pharmacogenomics: A focus on antidepressants and atypical antipsychotics
por: Lister, Jonathan F.
Publicado: (2016)

Pharmacogenomic testing and antidepressant response: problems and promises
por: Smith, Tawny L., et al.
Publicado: (2020)

The Potential Roles of Pharmacists in the Clinical Implementation of Pharmacogenomics
por: Maruf, Abdullah Al, et al.
Publicado: (2023)

The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations
por: Vaughn, Samuel E., et al.
Publicado: (2021)

Pharmacogenomics in Parkinson’s disease: which perspective for developing a personalized medicine?
por: Ciccacci, Cinzia, et al.
Publicado: (2019)

Expanding Pharmacist and Student Pharmacist Access to Genetics/Genomics/Pharmacogenomics Competency Education
por: Kisor, David F, et al.
Publicado: (2019)

Human pharmacogenomics: The development of a science
por: Kalow, Werner
Publicado: (2004)

Metformin Pharmacogenomics: Current Status and Future Directions
por: Pawlyk, Aaron C., et al.
Publicado: (2014)

Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments
por: Lin, Eugene, et al.
Publicado: (2021)

Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders
por: Bose-Brill, Seuli, et al.
Publicado: (2017)

Transitioning Pharmacogenomics into the Clinical Setting: Training Future Pharmacists
por: Frick, Amber, et al.
Publicado: (2016)

Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation
por: Bright, David, et al.
Publicado: (2020)

Pharmacists’ Knowledge, and Insights in Implementing Pharmacogenomics in Saudi Arabia
por: Alhaddad, Zahra Abdulathim, et al.
Publicado: (2022)

Are Community Pharmacists Ready to Deliver Pharmacogenomics Testing Services?
por: Ghazal, Heba, et al.
Publicado: (2023)

Antidepressants and Advertising: Psychopharmaceuticals in Crisis
por: Greenslit, Nathan P., et al.
Publicado: (2012)

Perspective: Advancing Dietary Guidance for Cognitive Health—Focus On Solutions to Harmonize Test Selection, Implementation, and Evaluation
por: Romijn, Amy R., et al.
Publicado: (2023)

FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”
por: Sabbagh, Marwan N., et al.
Publicado: (2019)

Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies
por: Gazzé, Gabriel
Publicado: (2018)

Pharmacogenomic alerts: Developing guidance for use by healthcare professionals
por: Carter, John‐Paul L., et al.
Publicado: (2022)

The role of dissociation in ketamine’s antidepressant effects
por: Ballard, Elizabeth D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2gm1h1208ai7jolg9uoovqb7s9